125I seed implant brachytherapy-assisted surgery with preservation of the facial nerve for treatment of malignant parotid gland tumors

Zhang, J.; Zhang, J.G.; Tao, Song; Lei, Zhen; Zhang, Y.; Zhang, K.H.; Yang, Zhiyuan; Yu, Guang‐Yan

doi:10.1016/j.ijom.2008.04.013

Cited by 46 publications

(31 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the present sample, FN paralysis was observed in one third of patients and was statistically related to a tumor diameter larger than 4 cm and high-grade malignant histology (<60% of patients). 15,16 Intentional FN resection was performed in 29 patients, but this entity retains a higher risk of recurrence; in this study population, the risk was 2.5-fold higher (18.7 vs 7%).…”

Section: Discussionmentioning

confidence: 72%

Treatment of Parotid Malignancies—10 Years of Experience

Kopeć

Mikaszewski

Jackowska

et al. 2015

Journal of Oral and Maxillofacial Surgery

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 72%

Treatment of Parotid Malignancies—10 Years of Experience

Kopeć

Mikaszewski

Jackowska

et al. 2015

Journal of Oral and Maxillofacial Surgery

View full text Add to dashboard Cite

“…In the treatment of head and neck cancers, particularly in parotid gland malignancies, [ 125 I] seed brachytherapy has earned a place as a viable treatment option, especially considering the decreased adverse side effects compared to EBRT [8][9][10][11]. Therefore, we focused our attention on radiation-induced skin side effects, which can significantly alter patient appearance.…”

Section: Outcomementioning

confidence: 99%

“…One of the methods of radiotherapy, [ 125 I] seed brachytherapy, has the advantage of having a high local control rate when treating head and neck cancers, especially in the treatment of parotid gland cancers [6][7][8][9][10][11]. In addition to the high local control rate, the lack of severe side effects is also beneficial, as this can improve the patient's quality of life during cancer treatment [8][9][10][11].…”

mentioning

confidence: 99%

See 1 more Smart Citation

The incidence of radioepidermitis and the dose-response relationship in parotid gland cancer patients treated with 125I seed brachytherapy

et al. 2014

View full text Add to dashboard Cite

“…Permanent brachytherapy has been proven an effective approach for the tumors located in prostate [1]- [4], thoracic cavity [5]- [8], head and neck [9]- [11] etc. In the operation, radioactive seeds are directly implanted into target volume via template and puncture needles.…”

Section: Introductionmentioning

confidence: 99%

A Double Iteration Greedy Heuristic Approach for Permanent Brachytherapy Planning

Liang¹,

Zhou²,

Liang³

et al. 2015

IJAPM

View full text Add to dashboard Cite

This paper presents a double iteration greedy heuristic (DIGH) approach for permanent brachytherapy treatment planning. The DIGH approach adopts a greedy heuristic seed selection (GHSS) procedure to obtain a preliminary plan. In this process, the potential seeds are evaluated according to their ability to irradiate target volume while sparing organs-at-risk (OARs). Their impact on dosimetric homogeneity within target volume is also taken into account. The preliminary treatment plan generated by the GHSS procedure is further refined by the double iteration (DI) procedure. The DI procedure removes the needles containing only one seed (single seed) and implements the GHSS procedure again to obtain a temporary plan. The DI procedure terminates when the needle number of the temporary plan does not decrease. This process is guided by constantly removing the undesired part rather than imposing extra constrains. The efficiency and robustness of the DIGH approach is tested on three kinds of typical patient cases. For these cases, treatment plans are generated in less than 30s. The dosimetric distribution of these treatment plans achieves satisfactory dosimetric distribution. The numbers of used needles are kept within acceptable level. The experimental results demonstrate that the DIGH approach is fast, effective and robust. It has the potential to be used for intraoperative brachytherapy treatment planning in operation room.

show abstract

125I seed implant brachytherapy-assisted surgery with preservation of the facial nerve for treatment of malignant parotid gland tumors

Cited by 46 publications

References 33 publications

Treatment of Parotid Malignancies—10 Years of Experience

Treatment of Parotid Malignancies—10 Years of Experience

The incidence of radioepidermitis and the dose-response relationship in parotid gland cancer patients treated with 125I seed brachytherapy

A Double Iteration Greedy Heuristic Approach for Permanent Brachytherapy Planning

Contact Info

Product

Resources

About